InvestorsHub Logo
Followers 14
Posts 733
Boards Moderated 0
Alias Born 12/09/2013

Re: None

Thursday, 08/05/2021 8:26:18 AM

Thursday, August 05, 2021 8:26:18 AM

Post# of 3016
Enanta Pharmaceuticals Announces Nomination of Clinical Candidate EDP-235, its Lead Oral Protease Inhibitor Specifically Designed for the Treatment of COVID-19
August 05, 2021

https://www.enanta.com/investors/news-releases/press-release/2021/Enanta-Pharmaceuticals-Announces-Nomination-of-Clinical-Candidate-EDP-235-its-Lead-Oral-Protease-Inhibitor-Specifically-Designed-for-the-Treatment-of-COVID-19/default.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News